VTE Risks and JAK inhibition
Mar 13, 2023
Daily Download
Comparing ACR21 vs EULAR22 RA Guidelines
Feb 22, 2023
Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines
JAKi Regulatory Decisions - FDA, EMA, Canada
Nov 15, 2022
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Smart Rules for Patients
May 10, 2022
DMARD and Biologic Safety Prescribing
Mar 21, 2022
Methotrexate Overview
Mar 14, 2022
The Scary Side of Steroids
Feb 09, 2022
COVID-19 & mRNA Vaccines
Jan 11, 2021
H2H Comparison
Dec 30, 2020
Arthritis Myths
Dec 07, 2020
2020 TNF Inhibitor Biosimilars
Nov 12, 2020